Telemedycyna Polska (WAR:TMP) Cyclically Adjusted Revenue per Share: zł1.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:TMP Telemedycyna Polska SA WAR:TMP
28 GF Score
Price zł0.65
GF Value zł0.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Telemedycyna Polska Cyclically Adjusted Revenue per Share?

Telemedycyna Polska WAR:TMP +1.56% 28 Cyclically Adjusted Revenue per Share is zł1.00 as of Mar. 2026. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Telemedycyna Polska's adjusted revenue per share for the three months ended in Mar. 2026 was zł0.105. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł1.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Telemedycyna Polska's average Cyclically Adjusted Revenue Growth Rate was -4.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Telemedycyna Polska was 1.30% per year. The lowest was -4.30% per year. And the median was -1.50% per year.

As of today (2026-08-02), Telemedycyna Polska's current stock price is zł0.65. Telemedycyna Polska's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was zł1.00. Telemedycyna Polska's Cyclically Adjusted PS Ratio of today is 0.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Telemedycyna Polska was 1.75. The lowest was 0.45. And the median was 1.10.


Telemedycyna Polska  (WAR:TMP) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Telemedycyna Polska's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.65/1.00
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Telemedycyna Polska was 1.75. The lowest was 0.45. And the median was 1.10.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Telemedycyna Polska Cyclically Adjusted Revenue per Share Related Terms


Telemedycyna Polska Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Telemedycyna Polska's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telemedycyna Polska Cyclically Adjusted Revenue per Share Chart

Telemedycyna Polska Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.13 1.11 1.06 0.99

Telemedycyna Polska Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.03 1.01 0.99 1.00

WAR:TMP vs VEEV, BTSG, HQY: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Telemedycyna Polska's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telemedycyna Polska Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Telemedycyna Polska's Cyclically Adjusted PS Ratio falls into.


WAR:TMP
28GF Score
Telemedycyna Polska SA WAR:TMP
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telemedycyna Polska Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Telemedycyna Polska's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.105/163.0700*163.0700
=0.105

Current CPI (Mar. 2026) = 163.0700.

Telemedycyna Polska Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.245 99.552 0.401
201609 0.238 99.064 0.392
201612 0.243 100.366 0.395
201703 0.236 101.018 0.381
201706 0.242 101.180 0.390
201709 0.240 101.343 0.386
201712 0.215 102.564 0.342
201803 0.251 102.564 0.399
201806 0.266 103.378 0.420
201809 0.194 103.378 0.306
201812 0.266 103.785 0.418
201903 0.198 104.274 0.310
201906 0.232 105.983 0.357
201909 0.166 105.983 0.255
201912 0.153 107.123 0.233
202003 0.149 109.076 0.223
202006 0.148 109.402 0.221
202009 0.154 109.320 0.230
202012 0.230 109.565 0.342
202103 0.148 112.658 0.214
202106 0.125 113.960 0.179
202109 0.129 115.588 0.182
202112 0.181 119.088 0.248
202203 0.187 125.031 0.244
202206 0.187 131.705 0.232
202209 0.195 135.531 0.235
202212 0.176 139.113 0.206
202303 0.132 145.950 0.147
202306 0.179 147.009 0.199
202309 0.207 146.113 0.231
202312 0.155 147.741 0.171
202403 0.112 149.044 0.123
202406 0.133 150.997 0.144
202409 0.128 153.439 0.136
202412 0.137 154.660 0.144
202503 0.122 157.021 0.127
202506 0.118 157.509 0.122
202509 0.128 158.000 0.132
202512 0.099 158.320 0.102
202603 0.105 163.070 0.105

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł1.00 mean?
Telemedycyna Polska (WAR:TMP) has a Cyclically Adjusted Revenue per Share of zł1.00 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Telemedycyna Polska and its competitors.
Is Telemedycyna Polska's Cyclically Adjusted Revenue per Share too high?
Telemedycyna Polska's current Cyclically Adjusted Revenue per Share is zł1.00. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
Telemedycyna Polska's Cyclically Adjusted Revenue per Share of zł1.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Telemedycyna Polska and its competitors. Telemedycyna Polska's current Cyclically Adjusted Revenue per Share is zł1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł1.00. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current Cyclically Adjusted Revenue per Share is zł1.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?

Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued. The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82. GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.

Key valuation signals for WAR:TMP:

  • Cyclically Adjusted Revenue per Share: zł1.00
  • GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
  • GF Score™: 28/100 with 5 warning signs

No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Telemedycyna Polska Business Description

Address Ulica Ligocka 103, Katowice, POL, 40-568
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score

Get the complete analysis for WAR:TMP

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.65
Price
zł0.82
GF Value